Упрощенная HTML-версия
141
159.
Saraiya B. Management of venous thromboembolism and the potential to
impact overall survival in patients with cancer / B. Saraiya, S. Goodin //
Pharmacotherapy. – 2009. – Vol. 29, № 11. – P. 1344-1356.
160.
Statin use and the risk of breast and prostate cancer / P. F. Coogan [et al.] //
Epidemiology. – 2002. – Vol. 13. – P. 262-267.
161.
Statins and prostate cancer risk: a case-control study / J. Shannon [et al.] //
Am. J. Epidemiol. – 2005. – Vol. 162. – P. 318-325.
162.
Statins and risk of cancer: A retrospective cohort analysis of 45,857
matched pairs from an electronic medical records database of 11 million
adult Americans / C. Marelli [et al.] // J. Am. Coll. Cardiol
.–
2011. – Vol.
58, № 5. – P. 530-537.
163.
Statins and the risk of colorectal cancer / J. N. Poynter [et al.] // N. Engl. J.
Med. – 2005. – Vol. 352. – P. 2184-2192.
164.
The association between 3–hydroxy–3–methylglutaryl coenzyme A inhibi-
tor use and breast carcinoma carcinoma risk among postmenopausal wom-
en: a case-control study / D. M. Boudreau [et al.] // Cancer. – 2004. – Vol.
100. – P. 2308-2316.
165.
The effect of pravastatin on coronary events after myocardial infarction in
patients with average cholesterol levels. Cholesterol and Recurrent Events
Trial investigators / F. M. Sacks [et al.] // N. Engl. J. Med. – 1996. – Vol.
335. – P. 1001-1009.
166.
The role of statins in cancer therapy / K. Hindler [et al.] // Oncologist. –
2006. – Vol. 11. – P. 306-315.
167.
Thompson H. J. Effect of exercise intensity and duration on the induction
of mammary carcinogenesis / H. J. Thompson // Cancer Res. – 1994. – Vol.
54, № 7. – P. 1960-1963.
168.
Use of multiple biomarkers for evaluation of anthracycline-induced cardio-
toxicity in patients with acute myeloid leukemia / J. M. Horacek [et al.] //
Exp. Oncol. – 2008. – Vol. 30, № 2. – P. 157-159.